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Abstract
Increasing evidence suggests that lycopene, the major carotenoid present in tomato, may be preventive against smoke-
induced cell damage. However, the mechanisms of such a prevention are still unclear. The aim of this study was to
investigate the role of lycopene on the production of the pro-inflammatory cytokine IL-8 induced by cigarette smoke and
the possible mechanisms implicated. Therefore, human THP-1 macrophages were exposed to cigarette smoke extract (CSE),
alone and following a 6-h pre-treatment with lycopene (0.5–2 mM). CSE enhanced IL-8 production in a time- and a dose-
dependent manner. Lycopene pre-treatment resulted in a significant inhibition of CSE-induced IL-8 expression at both
mRNA and protein levels. NF-kB controlled the transcription of IL-8 induced by CSE, since PDTC prevented such a
production. Lycopene suppressed CSE-induced NF-kB DNA binding, NF-kB/p65 nuclear translocation and phosphorylation
of IKKa and IkBa. Such an inhibition was accompanied by a decrease in CSE-induced ROS production and NOX-4 expression.
Lycopene further inhibited CSE-induced phosphorylation of the redox-sensitive ERK1/2, JNK and p38 MAPKs. Moreover, the
carotenoid increased PPARc levels which, in turn, enhanced PTEN expression and decreased pAKT levels in CSE-exposed
cells. Such effects were abolished by the PPARc inhibitor GW9662. Taken together, our data indicate that lycopene
prevented CSE-induced IL-8 production through a mechanism involving an inactivation of NF-kB. NF-kB inactivation was
accompanied by an inhibition of redox signalling and an activation of PPARc signalling. The ability of lycopene in inhibiting
IL-8 production, NF-kB/p65 nuclear translocation, and redox signalling and in increasing PPARc expression was also found in
isolated rat alveolar macrophages exposed to CSE. These findings provide novel data on new molecular mechanisms by
which lycopene regulates cigarette smoke-driven inflammation in human macrophages.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a syndrome
characterized by progressive airflow limitation caused by chronic
inflammation of the airways and lung parenchyma, which is due
predominantly to chronic cigarette smoking [1]. Chronic exposure
to cigarette smoke activates an inflammatory cascade in the
airways resulting in the production of a number of cytokines and
chemokines, with accompanying damage to the lung epithelium
and increased vascular permeability and recruitment of macro-
phages and neutrophils [2,3]. Macrophages are the major defence
cells in the lower airways of the lung in healthy nonsmokers and
appear to have an essential role in the pathogenesis of COPD by
accounting for most known features of the disease [4]. Broncho-
alveolar lavage (BAL) fluid from smokers compared to nonsmokers
show a five-fold increase in the number of inflammatory cells in
the lung, of which 85–90% are alveolar macrophages. Macro-
phages are predominant cells in the respiratory bronchioles of
smokers; studies have shown a correlation between alveolar
macrophage numbers and the extent of lung destruction in
emphysema [5,6].
The human chemokine IL-8 in particular, a member of the
CXC chemokine family, activates adhesion molecules expression
on endothelial cells [7] and it is an important activator and chemo-
attractant for neutrophils [8] as well as T cells [9] and monocytes
[10]. Increased levels of IL-8 have been found in induced sputum
[11] and bronchoalveolar lavage from patients with smoking-
related COPD associated with increased numbers of activated
neutrophils [12] . Therefore, IL-8 has been implicated in the
initiation and maintenance of chronic airway inflammation
induced by cigarette smoke.
Cigarette smoke harbors a multitude of chemical compounds,
including high concentrations of free radicals and other oxidant
species [13] and causes direct oxidative lung damage and indirect
damage through the activation of various lung cells including
alveolar macrophages [14]. Therefore, reactive oxygen species
(ROS) present in smoke and phagocyte-derived ROS are intimately
involved in the pathogenesis of smoking-related inflammation.
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Nuclear factor-kB (NF-kB) is one of the redox-sensitive
transcription factors involved in the inflammatory responses to
cigarette smoke in the lungs and its activity is regulated by
cytoplasmic degradation of the IkB inhibitor [15]. NF-kB dimers
localize to the nucleus, once IkBa is inactivated, and undergo
further modification, mostly through phosphorylation of the Rel
proteins [15]. In the nucleus activated NF-kB binds to promoters
of its target genes and regulates the expression of genes involved in
many cellular events, including inflammation [16] through the
activation of the Akt/phosphoinositide 3-kinase (PI3K) and the
mitogen-activated protein kinase (MAPK) cascade [17–20].
It is known that peroxisome proliferator activated receptor-c
(PPARc), a member of the ligand activated nuclear receptor
superfamily, is able to regulate anti-inflammatory responses in cells
exposed to cigarette smoke and that ligand-activated PPARc is
able to down-regulate NF-kB transcription. Recently, reports show
that upregulation of phosphatase and tensin homolog deleted on
chromosome 10 (PTEN), with the concomitant downregulation of
PI3K-dependent signaling pathways [21–23], might be one of the
mechanisms through which PPARc agonists exert their anti-
inflammatory actions.
Beneficial effects of tomato lycopene on the risk of smoke-
related pathologies, including cancer and cardiovascular injury,
have been found in epidemiological studies [24]. However, the
experimental basis for such health benefits is not fully understood.
One of the possible mechanisms for the protective activities of
lycopene in smoke-related pathologies is by down-regulation of the
cigarette smoke-stimulated inflammatory response [25,26]. In fact,
the carotenoid has been reported to inhibit pivotal pro-
inflammatory mediators, including ROS [27] and cytokines [28]
and to affect signal transduction pathways involved in inflamma-
tory processes, including nicotinamide adenine dinucleotide
phosphate oxidase oxidase [NADP(H)-oxidase] [28], MAPK
[29], Akt/PI3K [30] and transcription factors, such as activator
protein-1 (AP-1) [31] and NF-kB [31–35] and PPARc cascade
[28]. We recently reported that lycopene may inhibit ROS
production, NOX-4 expression and cytokine release in human
macrophages exposed to oxysterols [28]. Moreover, in the same
model, it may enhance PPARc expression [28].
To better understanding the role of lycopene in inflammatory
processes caused by cigarette smoke, we investigated the effect of
lycopene in modifying molecular pathways involved in cigarette
smoke extract (CSE)-induced IL-8 production in human macro-
phages. Use of CSE remains a good practical model to study
changes in cellular responses induced by cigarette smoke, since it
mimics the in vivo soluble cigarette smoke components that are
present during cigarette smoking. Here, we provide evidence of
the inter-relationships between the signalling networks activated
by cigarette smoke-induced stress and the anti-inflammatory effect
of lycopene in macrophages.
Results
Lycopene inhibition of CSE-induced IL-8 production and
NF-kB activation
Cigarette smoke induces a multitude of direct and indirect
effects on lung tissue, but it is principally responsible for
inflammation resulting in accumulation of macrophages and
release of chemical mediators, which changes lung functions,
morphology and gene expression. Since it has been reported that
exposure to cigarette of macrophages stimulates release of different
pro-inflammatory cytokines, including IL-8 [36] we measured the
effect of different concentrations of CSE on intracellular IL-8
production in THP-1 cells incubated for 6 h and 24 h (Fig. 1A).
CSE induced a dose- and a time- dependent increase in IL-8
production. A 6-h pre-treatment with lycopene at 2 mM, the
maximum concentration which can be achievable in vivo after
supplementation [37], down-regulated the production of IL-8
induced by CSE (Fig. 1B). Such an effect was dependent on the
dose of carotenoid (Fig. 1C) and also occurred at mRNA levels
(Fig. 1D). Similar results were found in the culture medium
(Fig. 1E). A 6-h pre-treatment with lycopene reduced the increase
of IL-8 production in culture medium induced by a 24-h treatment
with CSE. These data show an anti-inflammatory potential of
lycopene in CSE-exposed macrophages.
Since it has been reported that IL-8 levels are modulated by NF-
kB, we, then, investigated the effect of the specific NF-kB inhibitor
pyrrolidine dithiocarbamate (PDTC) on CSE-induced IL-8
production in THP-1 cells. The pre-incubation of THP-1 cells
with PDTC (10 mM) for 30 min prevented IL-8 protein produc-
tion (Fig. 2A), demonstrating the key role of this transcription
factor in CSE-stimulated IL-8 production by human macrophag-
es. We further analysed the effects of CSE, alone and in
combination with lycopene, on NF-kB DNA-binding activity in
THP-1 cells. Nuclear extracts were prepared and NF-kB DNA
binding activity was examined by EMSA. As shown in Figure 2B,
a 3 h-treatment of the THP-1 cells with CSE resulted in an
increase of the NF-kB DNA-binding activity. A 6-h pre-treatment
with lycopene, at the concentration of 2 mM, inhibited CSE-
mediated NF-kB DNA-binding activity. On the other hand, when
compared to vehicle-control treated cells, no significant alterations
in the DNA-binding activity were observed in lycopene alone-
treated cells, suggesting that the NF-kB DNA-binding activity
expression may not be substantially affected by physiological
concentrations of the carotenoid. Moreover, CSE induced the
translocation of NF-kB/p65 to the nucleus and lycopene pre-
treatment suppressed it (Figure 2C). To determine whether the
inhibitory action of lycopene towards NF-kB activation was due to
its effect on IkBa degradation, the cytosolic levels of IKKa and
IkBa were determined by Western blot analysis in cells treated
with lycopene and CSE (Fig. 2D). Western blot analysis showed
that CSE exposure resulted in phosphorylation of IKKa and pre-
treatment of THP-1 cells with lycopene inhibited this phosphor-
ylation (Fig. 2D). Further examining the effect of lycopene on IkBa
phosphorylation by Western blot analysis, using an antibody that
detects only the serine-phosphorylated form of IkBa, we found
that CSE exposure resulted in increased phosphorylation of IkBa
(Fig. 2D). Our data show that lycopene treatment of THP-1 cells
suppressed this phosphorylation. These findings indicate that
lycopene treatment of THP-1 cells resulted in inhibition of CSE-
induced activation of IKKa, phosphorylation and degradation of
IkBa, and subsequent activation of NF-kB.
Lycopene inhibition of CSE-stimulated redox signalling
It is known that NF-kB is activated by ROS and several lines of
evidence suggest that cigarette smoke is a source of ROS. Moreover,
cigarette smoke constituents can directly activate vascular ROS
production through induction of NAD(P)H oxidase. Therefore, we
measured ROS levels in the absence and in the presence of
diphenyleneiodonium (DPI), an inhibitor of cellular NADPH
oxidase in THP-1 cells exposed to CSE (Fig. 3A). Exposure of
THP-1 cells to CSE, caused an increase in ROS production. Such
an effect was evident at 3 h, and persisted at 24 h. When cells were
pre-incubated with DPI at the concentration of 10 mM for 1 h and
then washed prior to the addition of CSE, CSE-induced ROS
production was abolished, suggesting that, at least in our
experimental conditions, ROS production was generated intracel-
lularly and not extracellularly by smoke. Pre-treatment of THP-1
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cells with lycopene, at the concentration of 2 mM was able to
prevent CSE-induced ROS production (Fig. 3B). Only slight and
not significant inhibitory effects on ROS production by lycopene
were observed in CSE-untreated THP-1 cells. The carotenoid was
also able to inhibit the increase in NAD(P)H oxidase-4 (NOX-4)
expression caused by CSE (Fig. 3C). Such an effect was evident at
3 h as well as at 24 h. Generation of oxidants by cigarette smoke
appears to be the primary stimulus for activation of MAPK
cascades. Whether the inhibitory effect of lycopene on CSE-induced
ROS production extends to MAPK signalling pathway was
investigated in THP-1 cells. Employing Western blot analysis, we
found that a 3 h-CSE exposure resulted in a significant increase in
the phosphorylation of JNK (Fig. 4A) ERK1/2 (Fig. 4B) and p38
(Fig. 4C) MAPK proteins in THP-1 cells. The levels of p-ERK1/2
were markedly higher than those of p-p38 and p-JNK. Pre-
treatment with lycopene, at the concentration of 2 mM, resulted in a
marked reduction in the CSE-induced phosphorylation of p38,
ERK1/2 and JNK1/2 MAPK proteins, suggesting that the
carotenoid is an effective inhibitor of these pathways.
Lycopene enhancement of CSE-inhibited PPARc
signalling
PPARc has been shown to regulate anti-inflammatory responses
in CSE-exposed cells and ligand-activated PPARc has been
reported to down-regulate NF-kB transcription. Therefore, we
measured the levels of PPARc in THP-1 cells pre-treated for 6 h
with lycopene and then exposed to CSE (Figs. 5A and 5B). Our
results show that CSE decreased PPARc at mRNA (Fig. 5A) and
protein (Fig. 5B) levels. On the other hand, lycopene alone was
able to increase the expression of this transcription factor at both
mRNA and protein levels. Lycopene, in association with CSE,
prevented the decrease in PPARc levels induced by CSE,
maintaining very high levels of this transcription factor.
Figure 1. Effects of Cigarette smoke extract (CSE), alone and in combination with lycopene, on IL-8 production in human THP-1
cells. Panels A-D: intracellular IL-8 production; panel E: IL-8 production in culture medium. Panel A: effects of different CSE concentrations for 6 h and
24 h; panels B, D, E: effects of a pre-treatment for 6 h with lycopene (2 mM) followed by a 24-h CSE (0.5%) exposure; panel C: effects of a pre-
treatment with different concentrations of lycopene followed by a 24-h CSE (0.5%) exposure; Panels A, B, C: representative Western Blot analyses; the
values indicated represented the ratio of IL-8 and actin. Panel D: mRNA levels by reverse transcription polymerase chain reaction. Panel E: the values
were the means6 SEM of three independent experiments. Panel E: the values were the means6 SEM of three independent experiments. Values not
sharing the same letter were significantly different (P,0.05, Fisher’s test).
doi:10.1371/journal.pone.0019652.g001
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Since PPARc could exert its anti-inflammatory actions through
an up-regulation of phosphatase and tensin homolog deleted on
chromosome 10 (PTEN), THP-1 cells were treated with lycopene
and CSE, alone and in combination, and PTEN expression was
measured in the absence and in the presence of GW9662, an
irreversible antagonist of PPARc (Fig. 5C). Lycopene alone
induced a ten-fold up-regulation of PTEN in THP-1 cells
(Fig. 5C). Lycopene also induced an increase in the levels of
PTEN in the presence of CSE (from 0.2 to 0.9), but this increase
was much lower than that observed in cells treated with lycopene
alone (0.9 vs 3.2), although PPARc expression was not significant
different in the two treatments. In contrast, CSE alone did not
significantly modify PTEN expression, suggesting that the pro-
inflammatory effects of CSE did not involve changes in this
phosphatase. (Fig. 5C). However, the strong dependency of
PTEN expression by PPARc in cells treated with lycopene alone
is suggested by the results obtained in the presence of GW9662. A
6-h pre-incubation with 10 mM GW9662 completely prevented
the increase in PTEN expression induced by the carotenoid.
GW9662 was also able to prevent the increase in PTEN
expression induced by lycopene and CSE in combination,
although in a minor extent.
It has been hypothesized that the up-regulation of PTEN
could result in AKT inactivation. Therefore, we measured the
levels of pAKT in THP-1 cells treated with lycopene and CSE,
alone and in combination, in the absence and in the presence of
GW9662 (Fig. 5D). Pre-treatment of THP-1 cells with lycopene
induced a marked reduction in the CSE-induced phosphoryla-
tion of AKT, which was prevented by a 6-h pre-incubation with
10 mM GW9662 (Fig. 5D). These data suggest that the anti-
inflammatory effects of lycopene (increase of PTEN expression
and decrease in AKT phosphorylation) are PPARc dependent.
In contrast, THP-1 cells treated with CSE alone strongly
increased AKT phosphorylation, but such an increase was
independent of PPARc, since pAKT expression was not
modified by GW9662.
Figure 2. Effects of lycopene on CSE-stimulated NF-kB activation in human THP-1 cells. Panel A: IL-8 production in culture medium after
addition of the NF-kB inhibitor pyrrolidine dithiocarbamate (PDTC). THP-1 cells were pre-incubated with PDTC (10 mM) for 30 min and, then treated
with CSE was added for 3 h and 24 h. Panel B: NF-kB DNA binding activity in cells pre-treated for 6 h with lycopene (2 mM) and, then exposed to CSE
(0.5%) for 3 h; the specifity was demonstrated by using excess unlabeled NF-kB oligonucleotides ( = cold ssNF-kB) which competed away binding.
Panel C: representative western blot analysis of nuclear NF-kB (p65)-associated proteins in cells pre-treated for 6 h with lycopene (2 mM) and, then
exposed to CSE (0.5%) for 3 h; panel D: representative western blot analyses of cytosolic p-IKKa and p-IkBa in cells pre-treated for 6 h with lycopene
(2 mM) and, then exposed to CSE (0.5%) for 3 h; the values indicated represented the ratio protein/actin. In panel A, values were the means 6 SEM of
three experiments. Values not sharing the same letter were significantly different (P,0.05, Fisher’s test).
doi:10.1371/journal.pone.0019652.g002
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Effects of lycopene on IL-8 expression, NF-kB/p65 nuclear
translocation, ROS production and and PPARc expression
in isolated rat alveolar macrophages exposed to CSE
The ability of lycopene to modulate IL-8 production, redox and
PPARc signalling induced by CSE was also studied in rat alveolar
macrophages (AMs) isolated from bronchoalveolar lavages (BALs).
After the isolation of the cells and their incubation in culture
conditions, the AMs were treated with lycopene and CSE, alone
and in combination, in the experimental conditions indicated for
THP-1 cells (Fig. 6). A 6-h pre-treatment with lycopene at the
concentration of 2 mM was able to decrease CSE-induced IL-8
mRNA expression (Fig. 6A), NF-kB/p65 nuclear translocation
(Fig. 6B), ROS production (Fig. 6C) and to increase PPARc
expression (Fig. 6D), confirming a key role of lycopene in the
inhibition of inflammatory response induced by cigarette smoke.
Discussion
It is widely recognized that cigarette smoke caused an
inflammatory response [1]. According with this, smoking is the
major risk factor for chronic obstructive pulmonary disease (COPD)
and lung fibrosis, pathological processes characterized by pulmo-
nary leukocyte infiltration, chronic inflammation and progressive
tissue destruction [1]. It has been reported that exposure to cigarette
smoke of cultured human bloodmonocytes or macrophagic cultures
stimulates release of several pro-inflammatory cytokines, including
IL-8 [38–45]. In addition, fibroblasts [46–48] bronchial [49,50] and
alveolar [51] epithelial cells, which are the primary target for any
inhaled environmental agent, have been reported to release IL-8,
when exposed to cigarette smoke. In our study, the acute exposition
to CSE up-regulated IL-8 expression of human THP-1 macro-
phages at both mRNA and protein levels in a dose- and a time-
dependent manner. In contrast, pre-treatment with lycopene, in a
range of concentrations which can be achievable in vivo after
supplementation [37], was able to counteract this effect, suggesting
that the carotenoid may have a key role in regulating smoke-
induced inflammatory processes. This finding is in agreement with
previous observations showing a down-regulation of pro-inflamma-
tory cytokine expression by lycopene in in vitro and in vivo models
[28,52–56]. An inhibition of pro-inflammatory cytokine levels,
including IL-8, has been observed following treatment with other
carotenoids, including b-carotene [57,58]. In particular, b-carotene
has been reported to arrest the increase in IL-6 and IL-8 induced by
a long-term cigarette smoke exposition in serum, bronchoalveolar
lavage fluid and lung tissue of rats [57]. Moreover, b-carotene had
an inhibitory effect on IL-8 and TNF-a secretion in phorbol-12-
myristate-13-acetate-stimulated HL-60 cells, although such an
inhibition was observed at low (2 mM) but not at high (20 mM)
carotenoid concentrations [58]. In agreement with the literature
[49,59–61] our data show that the production of the pro-
inflammatory cytokine IL-8 by CSE is strongly linked to activation
of NF-kB, since PDTC, a chemical that stabilizes the NF-kB/IkB-a
complex [62] and inhibits the nuclear translocation of activated NF-
kB, significantly inhibited it. Therefore, lycopene potential ability to
Figure 3. Effects of lycopene on CSE-induced reactive oxygen species (ROS) production in human THP-1 cells. Panel A: ROS levels after
addition of the NAD(P)H oxidase-4 (NOX-4) inhibitor diphenyleneiodonium (DPI) in cells exposed to CSE for 3 h and 24 h. Cells were pre-incubated
with DPI at the concentration of 10 mM for 1 h and then washed prior to the addition of CSE. Panel B: ROS levels in cells pre-treated for 6 h with
lycopene (2 mM) and, then exposed to CSE (0.5%) for 3 h and 24 h. Panel C: representative western blot analysis of NOX-4 in cells pre-treated for 6 h
with lycopene (2 mM) and, then exposed to CSE (0.5%) for 3 h and 24 h; the values indicated represented the ratio NOX-4/actin. In panels A and B,
values were the means 6 SEM of five experiments. Values not sharing the same letter were significantly different (P,0.005, Tukey’s test).
doi:10.1371/journal.pone.0019652.g003
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influence cytokine levels may be, at least in part, explained by
carotenoid localization in or within cell membrane, modulating
surface molecules for primary immune response, which activate
signalling pathways responsible for modulation of NF-kB. Accord-
ing with this hypothesis, our data also show that lycopene may
counteract the effect of CSE on NF-kB activation. The inhibition of
NF-kB DNA binding activity by lycopene was mediated through
the downregulation of IKKa and IkB phosphorylation, and NF–kB
p65 subunit translocation from cytosol to nucleus. Increasing
evidence suggests that lycopene inhibited the binding activity of NF-
kB [32,33]. Moreover, tomato lycopene extract prevented lipo-
polysaccharide (LPS)-induced pro-inflammatory gene expression by
blocking NF-kB signalling [35]. Based on data showing that one of
the early events occurring in smoke-exposed cells is the increase in
ROS levels, we examined the possibility that ROS were involved in
NF-kB activation. We believe that the intracellularly generated
ROS trigger the effects of smoke in THP-1 cells, on the basis of our
experiments showing that diphenyleneiodonium (DPI), an inhibitor
of cellular NADPH oxidase, was able to abolish the presence of
ROS in CSE-exposed macrophages. Concomitantly, CSE was able
to increase NOX-4 expression in THP-1 cells. In our study,
lycopene inhibited both CSE-induced ROS production and CSE-
stimulated NOX-4 expression. This is not surprising since the
carotenoid has been reported to act as an intracellular redox agent,
at least in vitro conditions [26]. Due to its extended system of
conjugated double bonds, lycopene can effectively quench singlet
oxygen [27] and free radicals [63] generated by smoking exposure.
Moreover, recent data suggest that the carotenoid may also inhibit
NOX-4 expression in human macrophages exposed to oxidants
[28,64].
The MAP kinases (ERK1/2, p38 and JNK) have been reported
to be activated by oxidant stimuli and to mediate production of
cytokines via NF-kB activation [25,65–67]. Whether the inhibitory
effect of lycopene on CSE-induced NF-kB activation pathway
extends to MAPK signalling pathway was investigated. Employing
Western blot analysis, we found that CSE exposure to THP-1 cells
resulted in a significant increase in the phosphorylation of p38,
ERK1/2, and JNK1/2 MAPK proteins. On the other hand,
lycopene treatment resulted in a marked reduction in the CSE-
induced phosphorylation of the three redox-sensitive MAPK
proteins as shown in Figure 4, suggesting that lycopene is an
effective inhibitor of MAPK pathways in THP-1 cells. The findings
that lycopene can reduce MAPK activation in human macrophages
confirm previous evidence in LPS-stimulated murine bone marrow-
dendritic cells [29] and in oxysterol-exposed THP-1 cells [28] .
It has been reported that nicotine and the tobacco-specific
carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, two
components of cigarette smoke, induce phosphorylation of AKT
(pAKT) in non-immortalized human airway epithelial cells [68].
Moreover, pAKT has been reported to activate NF-kB signalling
and the consequent expression of pro-inflammatory cytokines. We
therefore tested the effect of lycopene on CSE-induced activation
of AKT. For this, protein lysates were analysed by Western blot
using antibodies that detect the phosphorylated form of this
protein. As shown in Figure 4, CSE exposure to THP-1 cells
resulted in increased AKT phosphorylation, and lycopene
treatment suppressed it.
A recent in vitro study also suggests that lycopene may have a key
role in the modulation of AKT pathway under smoke conditions
[30]. In fact, while RAT-1 fibroblasts exposed to cigarette smoke
condensate exhibited high levels of phosphorylated AKT, cells
exposed to a combination of tar and lycopene strongly decreased
them. Moreover, in the same study, the expression of the heat
shock protein (hsp)90 was increased following tar exposure [30].
Such an increase was counteracted by lycopene. This finding is
particularly interesting in view of a previous report showing that
hsp90 maintains Akt activity by binding to Akt and by preventing
PP2A-dependent dephosphorylation of Akt [69]. Moreover, hsp90
has been reported to prevent proteasome-dependent degradation
of PDK1, which is known to activate Akt.
Figure 4. Effects of lycopene on CSE-induced MAPK phosphorylation in human THP-1 cells. Representative western blot analyses of JNK,
ERK1/2 and p38 in cells pre-treated for 6 h with lycopene (2 mM) and, then exposed to CSE (0.5%) for 3 h. The values indicated represented the ratio
phosphorylated protein/total protein.
doi:10.1371/journal.pone.0019652.g004
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PPARc has been implicated in anti-inflammatory response and
increasing evidence suggests that cigarette smoke strongly reduced
it [70]. PPARc activation has been shown to inhibit pro-
inflammatory cytokine production by preventing activation and
translocation of NF-kB [71]. In our study, lycopene was able to
increase PPARc at both mRNA and protein levels, confirming
previous reports [28]. Moreover, the carotenoid, counteracted the
decrease in PPARc induced by CSE. Recently, it has been shown
that upregulation of phosphatase and tensin homolog deleted on
chromosome 10 (PTEN), with the concomitant downregulation of
PI3K-dependent signaling pathways, might be another mecha-
nism through which PPARc exerted its anti-inflammatory actions.
Therefore, we investigated the effects of lycopene on PTEN
expression. Pre-treatment of THP-1 cells with the carotenoid
increased PTEN expression and decreased Akt phosphorylation.
However, it should be pointed out that the increase in PTEN
expression by lycopene in the presence of CSE was much lower
than that observed in the presence of lycopene alone, although
PPARc expression was not significant different in the two
treatments. Interestingly, GW9662, which is an irreversible
antagonist of PPARc, prevented the increase in PTEN and the
decrease in pAKT induced by lycopene, suggesting that PTEN
activation required an increase in PPARc levels and antagonized
the phosphorylation of Akt. It has been suggested that lycopene
may have a PPARc agonist activity [72,73]. In THP-1 cells [72] as
well as in LNCaP cells [73], the specific antagonist of PPARc
(GW9662) reverted the PPARc-mediated effects of lycopene on
cholesterol metabolism [72] and/or cell proliferation [72,73]. In
addition, Sharoni and colleagues have proposed that some
carotenoids, such as lycopene, phytoene, phytofluene, and b-
carotene cause the transactivation of peroxisome proliferator
response element in cells co-transfected with PPARc [74]. In
contrast, CSE alone did not exert pro-inflammatory effects
through a down-regulation of PPARc expression, since CSE
Figure 5. Effects of lycopene on CSE-inhibited PPARc signalling in human THP-1 cells. Panel A: PPARc mRNA and panel B: representative
western blot analysis of PPARc protein cells pre-treated for 6 h with lycopene (2 mM) and, then exposed to CSE (0.5%) for 3 h. Panel C: representative
western blot analysis of PTEN in cells pre-treated for 6 h with lycopene (2 mM) and/or with the PPARc inhibitor GW9662 and, then exposed to CSE
(0.5%) for 24 h. Panel D: representative western blot analysis of AKT in cells pre-treated for 6 h with lycopene (2 mM) and/or with the PPARc inhibitor
GW9662 and, then exposed to CSE (0.5%) for 24 h. GW9662 was pre-incubated at the concentration of 10 mM. The values indicated represented the
ratio protein/actin (PTEN) and phosphorylated protein/total protein (AKT). In panel A, values were the means6 SEM of three experiments. Values not
sharing the same letter were significantly different (P,0.05, Fisher’s test).
doi:10.1371/journal.pone.0019652.g005
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treatment did not significantly affect PTEN expression and the
increase in CSE-induced AKT phosphorylation was unaffected by
GW9662.
In conclusion, CSE exposure of human THP-1 macrophages
caused an increase in the levels of the pro-inflammatory cytokine IL-
8 which occurred through activation of NF-kB. Pre-treatment of
cells with lycopene decreased both CSE-induced IL-8 production
and NF-kB activation. Two mechanisms, could be implicated in
such anti-inflammatory response of lycopene. The first one involves
an interference with redox signalling, demonstrated by decrease in
ROS production and in redox-sensitive MAPK activation by
lycopene. The second one involves, at least in part, a PPARc-
dependent activation of PTEN which results in Akt inactivation.
These findings thus represent a direct evidence that lycopene may
act as an anti-inflammatory compound in cells exposed to cigarette
smoke and provide novel data on important molecular mechanisms
by which lycopene regulates cigarette smoke-driven NF-kB-
dependent inflammation in human macrophages.
Materials and Methods
Cell culture
THP-1 (American Type Culture Collection, Rockville, MD,
USA) were grown in RPMI Dutch Modified (Sigma, Milan, Italy)
without antibiotics and supplemented with 10% fetal calf serum,
non essential aminoacids, 2 mM glutamine, and 1 mM sodium
piruvate. Cells were maintained in log phase by seeding twice a
week at density of 36108 cells/L at 37uC under 5% CO2/air
atmosphere. Lycopene (LycoRed Natural Products Industries Ltd,
Beer Sheva, Israel) was delivered to the cells (109 cells/L) using
tetrahydrofuran (THF) as a solvent. To avoid the formation of
peroxides, the solvent contained 0.025% butylated hydroxytoluene
(BHT). The stock solutions of lycopene were prepared immediately
before each experiment. From the stock solutions, aliquots of
lycopene were rapidly added to the culture medium to give the final
concentrations indicated. Control cultures were treated with THF +
BHT. The amount of THF added to the cells was not greater than
0.5% (v/v) and it was the same in control cells as well as in treated
ones. No differences were found between cells treated with THF
and untreated cells in terms of cell viability and ROS production.
After the addition of lycopene for 6 h, the medium was not further
replaced throughout the experiments. Experiments were routinely
carried out on triplicate cultures. At the times indicated, cells were
harvested and quadruplicate haemocytometer counts were per-
formed. The trypan blue dye exclusion method was used to evaluate
the percentage of viable cells. No differences were found between
vehicle control- and lycopene-treated cells, in the range of
carotenoid concentration indicated, in terms of cell viability.
Figure 6. Effects of lycopene, alone and in combination with cigarette smoke extract (CSE), on intracellular IL-8 mRNA levels, NF-
kB/p65 nuclear translocation, ROS production and PPARc expression in isolated rat alveolar macrophages (AMs). Panel A: IL-8 levels
by reverse transcription polymerase chain reaction in cells treated for 6 h with lycopene (2 mM) followed by a 24-h CSE (0.5%) exposure. Panel B:
representative western blot analysis of nuclear NF-kB (p65)-associated proteins in cells pre-treated for 6 h with lycopene (2 mM) and, then exposed to
CSE (0.5%) for 3 h. Panel C: ROS levels in cells pre-treated for 6 h with lycopene (2 mM) and, then exposed to CSE (0.5%) for 3 h. Panel D: PPARc:
representative western blot analysis of PPARc protein in cells pre-treated for 6 h with lycopene (2 mM) and, then exposed to CSE (0.5%) for 3 h. In
panels A and C, values were the means 6 SEM of three experiments. Values not sharing the same letter were significantly different (P,0.05, Fisher’s
test).
doi:10.1371/journal.pone.0019652.g006
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Isolation and culture of rat alveolar macrophages AMs
Male Wistar rats (232–305 g body weight) (Catholic University
laboratories, Rome, Italy) were used for isolation of AMs. After
rats were anesthetized by an intraperitoneal injection of ketamine
(90 mg/kg) and xylazine (5 mg/kg), the trachea were cannulated
and AMs were obtained by three bronchoalveolar lavages (BALs)
using 10 ml of Ca2+2 and Mg2+2free DPBS each time. Cells
recovered from the pooled BAL fluid were suspended in MEM
containing 0.02% BSA, 25 mM HEPES, 100 U/ml of penicillin,
and 100 mg/ml of streptomycin. The cells were seeded in either
24-well culture plates or 35 mm-diameter culture dishes. After
incubation for 2 h at 37uC in a 5% CO2 humidified atmosphere to
allow AMs to adhere, non-adherent cells were removed by
washing one time with complete medium. AMs were incubated
overnight to make them quiescent. Cell viability as determined by
trypan blue exclusion was .95% and the purity of AMs as
determined by non-specific esterase staining (Sigma- Aldrich) was
.90%. AMs from the same rat were used for the same series of
experiments to reduce inter-individual variation. All animal
procedures were reviewed and approved by the Ministry of
Health, Veterinary Service, Rome, Italy.
Preparation of aqueous cigarette smoke extract
Research grade cigarettes (1R3F) were obtained from the
Kentucky Tobacco Research and Development Center at the
University of Kentucky (Lexington, KY). The total particulate
matter (TPM) content of 1R3F was 17.1 mg/cigarette, tar (15 mg/
cigarette) and nicotine (1.16 mg/cigarette). A 10% cigarette smoke
extract (CSE) was prepared by bubbling smoke from one cigarette
into 10 ml of culture medium supplemented with 1% FBS at a rate
of one cigarette per minute as described previously, using a
modification of the method described by Carp and Janoff [75]. The
pH of the CSE was adjusted to 7.4 and was sterile filtered through a
0.45-mm filter (25-mm Acrodisc; Pall, Ann Arbor, MI). The CSE
preparation was standardized by monitoring the absorbance at
320 nm (optical density of 0.7460.05). The spectral variations
observed between different CSE preparations at 320-nm wave-
length were found to be within the acceptable limits. CSE was
freshly prepared for each experiment and diluted with culture
medium containing 1% FBS immediately before use. Control
medium was prepared by bubbling air through 10 ml of culture
medium supplemented with 1% FBS, adjusting pH to 7.4, and
sterile filtered as described for 10% CSE. The final concentration of
CSE was 0.5%. At this concentration, cell viability was always
greater than 95% as measured by trypan blue exclusion.
Chemiluminescence Immunometric Assay of IL-8
IL-8 was measured by a solid-phase, two-site chemilumines-
cence immunometric assay (Siemens Medical Solution Diagnos-
tics, LA, CA, USA). The intra and inter-assay CV for IL-8 was
,3.8 % and 6.7%. The detection limit was 2.0 pg/ml for IL-8.
Measurement of ROS
Cells were harvested to evaluate reactive oxygen species (ROS)
production using the di(acetoxymethyl ester) analog (C-2938) of 6-
carboxy-29,79-dichlorodihydrofluorescein diacetate (DCF) (Molec-
ular Probes, Inc., Eugene, OR) as described [76]. Before the
addition of the fluorescent probes, 26106 cells were washed to
eliminate the amount of lycopene not cell-associated. Fluorescent
units were measured in each well after 30 min incubation with
DCF (10 mM) by use of a Cytofluor 2300/2350 Fluorescence
Measurement System (Millipore Corp., Bedford, MA). Lycopene
did not alter the basal fluorescence of DCF.
Preparation of whole cell lysates, cytosolic and nuclear
extracts
Cells (106106) were harvested, washed once with ice-cold
phosphate-buffered saline (PBS), and gently lysed for 30 min in
ice-cold lysis buffer (1 mM MgCl2, 350 mM NaCl, 20 mM N-2-
hydroxyethylpiperazine-N9-2-ethane sulfonic acid (HEPES),
0.5 mM ethylenediaminetetraacetate (EDTA), 0.1 mM ethylene-
glycol-bis(b-aminoethyl ether)-N,N9-tetraacetic acid (EGTA),
1 mM dithiothreitol (DTT), 1 mM Na4P2O7, 1 mM PMSF,
1 mM aprotinin, 1.5 mM leupeptin, 1 mM Na3VO4, 20%
glycerol, 1% NP40). Cell lysates were centrifuged for 10 min at
4uC (10,000 g) to obtain the supernatants (whole cell lysate). For
the cytosolic extracts, the confluent cells were washed in ice-cold
PBS, suspended in ice-cold hypotonic buffer (10 mM HEPES,
pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.3% NP-40, 0.1 mM
EDTA, 0.1 mM EGTA, 0.5 mM DTT, 0.1 mM PMSF, 0.1%
aprotinin), and lysed for 15 min on ice. The lysates were
centrifuged for 10 min at 10 0006g. The supernatants were
designated as cytosolic extracts. The nuclear pellet was resus-
pended in the high salt lysis buffer (10 mM HEPES, 1.5 mM
MgCl2, 420 mM NaCl, 0.2 mM EDTA, 0.1 mM EGTA, 25%
glycerol, 0.5 mM DTT, 0.1 mM PMSF, 0.1% aprotinin), and
incubated at 4uC for 30 min. The resulting supernatants were
reserved as nuclear extracts. The protein concentrations of
samples were determined by Bio-Rad (Hercules, CA, USA)
protein assay.
Western blot analysis of IL-8, p65, p-IKKa, p-IkBa, IkBa,
Nox-4, p38 and p-p38, ERK1/2, pERK1/2, JNK, p-JNK,
PPARc, AKT, p-AKT and PTEN expression
The anti-IL-8 (H-60, Cat. no. SC-7922), anti-NOX-4 (N-15,
Cat. No. sc-21860), anti-p38 (C-20, Cat. No. SC-535), anti-
ERK1/2 (K-23, Cat. No. SC-94), , anti-JNK (C-17, Cat. No. SC-
474), , anti-PPARc (H-100, catalog. no. SC-7196), anti-AKT (C-
20, Cat. no. SC-1618), anti-pAKT (anti-p-Akt1/2/3 (Thr 308-R,
catalog. no. sc-16646-R), and anti-IKK (M280, Cat. no. SC-7182)
polyclonal antibodies and the anti-p65 (F-6, Cat. No. SC-8008), p-
p38 (D-8, Cat. No. SC-7973), anti p-ERK1/2 (E-4, Cat. No. SC-
7383), anti-p-JNK (G-7, Cat. No. SC-6254) and anti-PTEN (28H6
, Cat. No. SC-56205) monoclonal antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). The anti- IkBa and
the anti-p-IkBa (Ser32/36) monoclonal antibodies were obtained
from Cell Signaling Technology (Beverly, MA, USA). The blots
were washed and exposed to horseradish peroxidase-labeled
secondary antibodies (Amersham Pharmacia Biotech, Arlington
Heights, IL) for 45 min at room temperature. The immunocom-
plexes were visualized by the enhanced chemiluminescence
detection system and quantified by densitometric scanning.
RT-PCR of IL-8 and PPARc
Total RNA was extracted from cells samples using Trizol
according to manufacturer’s protocols (Invitrogen life technolo-
gies, Paisley U.K.) the RNA was eluted in DEPC treated water
(0.01% DEPC) and stored at 280u until RT-PCR analysis.
Nucleic acid concentrations were measured by spectrophotometry
(Hewlett-Packard HP UV/VIS spectrophotometer 8450).
RT-PCR assay was performed using the two-step method. For
the first-step of reverse transcription, we used QuantiTect
ReverseH Trancription kit (Qiagen, Hilden, Germany) with 500
gg of total RNA as template RNA, following the manufacturer’s
procedure. For the second step of real time PCR reactions, we
employed QuantiTect SYBRH Green Kits (Qiagen) and Quanti-
TectH Primer Assays (Qiagen) for human and rat b-Actin, IL-8,
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PPARc, according to manufacturer’s protocol described for the
real-time thermalcycler LightCycler (Roche). PCR data obtained
by the LightCycler software were automatically analysed by the
Relative Quantification Software (Roche) and expressed as target/
reference ratio. Our approach was based on the calibrator-
normalized relative quantification including correction for PCR
efficiency.
Electrophoretic Mobility-Shift Assay
Frozen cell pellets were processed to obtain nuclear extracts.
The pellet was treated as indicated in [35]. Binding reactions
containing 5 mg nuclear extracts, 10 mmol/L Tris-HCl (pH 7.6),
5 % glycerol, 1 mmol/L EDTA, 1 mmol/L DTT , 50 mmol/L
NaCl, and 3 mg poly(dI-dC) were incubated for 30 min with
5,000 cpm of a- 32P-end-labeled double-stranded oligonucleotide
in a total volume of 20 mL. The probe was 59-AGTTGAGGG-
GACTTTCCCAGGC39. Labeling of the probe was obtained by
incubating 5 pmol of oligonucleotide with 10 pmol [a-32P]ATP
and 3 UT4 polynucleotide kinase for 30 min at 37uC. The probe
was then purified with MicroBIO-Spin P-30 columns. Complexes
were separated on 60 g/L polyacrylamide gels with 45 mmol/L
Tris-borate, 1 mmol/L EDTA, pH 8 buffer. After fixation and
drying, gels were exposed on phosphor screens which were then
analyzed by phosphor/fluorescence imager STORM 840 (Molec-
ular and Dynamics, Sunnyvale, CA, USA). The intensity of the
revealed bands was directly quantified by Image QuaNT software
(Molecular Dynamics, Sunnyvale, CA, USA).
Analysis of p65 protein
Nuclear extracts, 25–30 mg of protein, were separated by
sodium dodecyl sulfate polyacrilamide gel electrophoresis with 40–
120 g/L Bis-Tris gels (NOVEX, San Diego, CA, USA) and
transferred to Immobilon-P membranes (Millipore Corp, Bedford,
MA, USA) with the use of a semidry system. Immunoblots were
blocked overnight at 4uC in 50 g/L dried milk in PBS, pH 7.4
plus 0.05% Tween 20. Blots were incubated with polyclonal
primary antibodies to p65 (Santa Cruz, Biotechnology, CA, USA,
clone 49.Ser 311, catalog no. SC-135769) in PBS plus 0.05%
Tween 20 for 1–2 h at room temperature. The blots were
visualized as described in Western blotting assay.
Statistical analysis
Three separate cultures per treatment were utilized for analysis
in each experiment. Values were presented as means 6 SEM.
One-way ANOVA was used to determine differences between the
treatments in Figs. 1D, 1E, 2A, 5A, 6A, 6C. When significant
values were found (P,0.05), post hoc comparisons of means were
made using Fisher’s test. Multifactorial two-way analysis of
variance (ANOVA) was adopted to assess any differences among
the treatments and the times in Figs. 3A, 3B. When significant
values were found (P,0.05), post hoc comparisons of means were
made using the Tukey’s Honestly Significant Differences test.
Differences were analyzed using Minitab Software (Minitab, Inc.,
State College, PA).
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